Enterprise Value
180.1M
Cash
55.6M
Avg Qtr Burn
-7.002M
Short % of Float
4.83%
Insider Ownership
1.08%
Institutional Own.
25.63%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Defencath Details Infectious disease, Catheter related blood stream infections | NDA Acceptance for review |